Private Equity Acquisition of Hospitals May Increase Adverse Events

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Dec. 26, 2023 -- Hospital-acquired adverse events are increased in association with private equity acquisition of hospitals, according to a study published in the Dec. 26 issue of the Journal of the American Medical Association.

Sneha Kannan, M.D., from Massachusetts General Hospital in Boston, and colleagues examined changes in hospital-acquired adverse events and hospitalization outcomes associated with private equity acquisitions of U.S. hospitals. Data from 100 percent Medicare Part A claims were compared for 662,095 hospitalizations at 51 private equity-acquired hospitals and 4,160,720 hospitalizations at 259 matched control hospitals not acquired by private equity.

The researchers found that hospital-acquired adverse events or conditions occurred in 10,091 hospitalizations. Compared with those treated at control hospitals, Medicare beneficiaries admitted to private equity hospitals experienced a 25.4 percent increase in hospital-acquired conditions (4.6 additional hospital-acquired conditions per 10,000 hospitalizations). This increase was driven by a 27.3 percent and a 37.7 percent increase in falls and central line-associated bloodstream infections, respectively, at private equity hospitals, despite placement of 16.2 percent fewer central lines. At private equity hospitals, there was a doubling of surgical site infections, from 10.8 to 21.6 per 10,000 hospitalizations, despite an 8.1 percent reduction in surgical volume; these infections decreased at control hospitals. Compared with control hospitals, there was a slight decrease in mortality at private equity hospitals (3.4 percent on average), but no differential change was seen in mortality by 30 days after discharge.

"These findings heighten concerns about the implications of private equity on health care delivery," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-27 06:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords